KIC
WST icon

Kensington Investment Counsel’s West Pharmaceutical WST Stock Holding History

Kensington Investment Counsel’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,097
Closed -$302K – 107
2025
Q4 		$302K Sell
1,097
-265
-19% -$72.5K 0.12% 96
2025
Q3 		$357K Sell
1,362
-335
-20% -$81.4K 0.15% 86
2025
Q2 		$371K Sell
1,697
-15
-0.9% -$3.21K 0.16% 82
2025
Q1 		$383K Sell
1,712
-47
-3% -$13K 0.17% 82
2024
Q4 		$576K Buy
1,759
+7
+0.4% +$2.2K 0.24% 81
2024
Q3 		$526K Buy
1,752
+47
+3% +$14.4K 0.22% 85
2024
Q2 		$562K Sell
1,705
-24
-1% -$8.48K 0.25% 83
2024
Q1 		$684K Buy
1,729
+149
+9% +$55.1K 0.31% 81
2023
Q4 		$556K Buy
1,580
+17
+1% +$6.02K 0.29% 80
2023
Q3 		$586K Buy
1,563
+124
+9% +$48K 0.36% 74
2023
Q2 		$550K Sell
1,439
-21
-1% -$7.5K 0.35% 79
2023
Q1 		$506K Sell
1,460
-135
-8% -$39.4K 0.38% 74
2022
Q4 		$375K Sell
1,595
-83
-5% -$19.7K 0.29% 75
2022
Q3 		$413K Buy
1,678
+8
+0.5% +$2.44K 0.35% 75
2022
Q2 		$505K Sell
1,670
-5
-0.3% -$1.63K 0.43% 73
2022
Q1 		$688K Sell
1,675
-2,286
-58% -$895K 0.46% 78
2021
Q4 		$1.86M Buy
+3,961
New +$1.7M 1.08% 40
2021
Q2 		$1.28M Buy
3,568
+65
+2% +$21.5K 0.88% 55
2021
Q1 		$987K Buy
3,503
+134
+4% +$38.4K 0.74% 69
2020
Q4 		$954K Buy
+3,369
New +$945K 0.79% 66

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kensington Investment Counsel's WST Position: Q1 2026 in Review

Kensington Investment Counsel sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 1,097 shares — an estimated $302K sold.

Kensington Investment Counsel first reported a position in WST in Q4 2020 and held it in 20 quarters. The position peaked at $1.86M in Q4 2021. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Kensington Investment Counsel reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Kensington Investment Counsel sold 1,097 West Pharmaceutical shares in Q1 2026, an estimated $302K.
  • Kensington Investment Counsel first reported a position in West Pharmaceutical in Q4 2020 and held it in 20 quarters.
  • Kensington Investment Counsel's West Pharmaceutical position peaked at $1.86M in Q4 2021.
  • 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Kensington Investment Counsel's 13F filing for Q1 2026, filed 19 May 2026.